| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | VL1I6P2DZ8 |
| InChI Key | TWQYWUXBZHPIIV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H17Cl2F3N4O2 |
| Molecular Weight | 449.26 |
| AlogP | 4.7 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 76.14 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Cannabinoid CB2 receptor agonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Cannabinoid receptor
|
50-437 | - | - | - | 12 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoarthritis | 2 | D010003 | ClinicalTrials |
| Pain | 2 | D010146 | ClinicalTrials |
| Osteoarthritis, Knee | 2 | D020370 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL225411 |
| DrugBank | DB11903 |
| EPA CompTox | DTXSID60216786 |
| FDA SRS | VL1I6P2DZ8 |
| SureChEMBL | SCHEMBL3015040 |
| ZINC | ZINC000003947932 |